{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T09:16:11Z","timestamp":1793610971471,"version":"4.5.0"},"reference-count":87,"publisher":"Informa UK Limited","issue":"14","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2025,12,6]]},"DOI":"10.1080\/10428194.2025.2560082","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T09:23:06Z","timestamp":1760088186000},"page":"2588-2600","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["CD19-directed chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma: lessons learned from clinical trials and real world evidence"],"prefix":"10.1080","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5144-3467","authenticated-orcid":false,"given":"Supriya","family":"Gupta","sequence":"first","affiliation":[{"name":"University of Minnesota","place":["Minneapolis, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9325-432X","authenticated-orcid":false,"given":"Veronika","family":"Bachanova","sequence":"additional","affiliation":[{"name":"University of Minnesota","place":["Minneapolis, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.366"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31366-0"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804980"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116133"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00662-6"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2024.06.003"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-769620"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00273-4"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.08.015"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.12.003"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01097"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.10.022"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015956"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-185035"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-174865"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-146268"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-146646"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-199890"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022018893"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01969-y"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02104"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.05.026"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-124750"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-127490"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003092"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00339-4"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-180242"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-184862"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.54"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01973"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.758"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S202015"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2020.1729735"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-203370"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.10.038"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2024.08.018"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.04.001"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024013688"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-169382"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-94353-0_27"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-023-02169-z"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-025-02541-1"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010624"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14061501"},{"issue":"1","key":"e_1_3_2_47_1","first-page":"181","article-title":"Characterisation of Early and Late Cytopenias in Lymphoma Patients following Treatment with anti-CD19 CAR-T Therapy","volume":"55","author":"Hockings C","year":"2020","unstructured":"Hockings C, Andrea K, Shu W, et\u00a0al. Characterisation of Early and Late Cytopenias in Lymphoma Patients following Treatment with anti-CD19 CAR-T Therapy. Bone Marrow Transplant. 2020;55(1):181\u2013714.","journal-title":"Bone Marrow Transplant"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00077-2"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017415"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022007776"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26914"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2024.07.018"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281719"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.03.006"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2025.02.005"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.284784"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00707-4"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024012573"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2400209"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2401361"},{"key":"e_1_3_2_61_1","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research. Considerations for the development of Chimeric Antigen Receptor (CAR) T cell products. https:\/\/www.fda.gov\/media\/156896\/download"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-022-01867-4"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023020197"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2024.02.019"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15184671"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18054"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-22-0487"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.7100"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-189154"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.12.015"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017414"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002394"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001900"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008294"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008240"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.12.005"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2023.11.007"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.048100"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017579"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/s44228-023-00037-7"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008865"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1080\/14796694.2024.2393566"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2022-0037"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40290-022-00428-w"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023012549"},{"key":"e_1_3_2_86_1","unstructured":"Food and Drug Administration. FDA Eliminates Risk Evaluation and Mitigation Strategies (REMS) for autologous Chimeric Antigen Receptor (CAR) T cell Immunotherapies. https:\/\/www.fda.gov\/vaccines-blood-biologics\/safety-availability-biologics\/fda-eliminates-risk-evaluation-and-mitigation-strategies-rems-autologous-chimeric-antigen-receptor"},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.04.008"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024013254"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2025.2560082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T07:30:28Z","timestamp":1765783828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2025.2560082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":87,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025,12,6]]}},"alternative-id":["10.1080\/10428194.2025.2560082"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2025.2560082","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}